The science behind
LumbaCure®

*Design under development

Support functional training

Support professionals

Suitable for all user profiles

Support athletic performance

Innovative robotic seat paired with user-interface

  • Addressing 4 targets: proprioception – muscle relaxion – mobilization – active user engagement.
  • Driven by a proprietary motion algorithm enabling monitored, controlled and reproducible physical sessions.
  • Unique mechanism of action imposing mobilization of the lower back, contrasting with passive solutions. By actively guiding and encouraging controlled mobilization of the lower back, LumbaCure supports functional training programs in delivering consistent movement patterns that contribute to positive outcomes.
  • Designed with six degrees of freedom (three rotations and three translations), enabling full-spectrum spinal mobilization in all directions, far beyond the limited movement patterns offered by traditional solutions.

New developments for Lumbacure®

We are advancing the LumbaCure® platform through:

  • A smart data-driven interface for therapists (under development and pending validation).
  • Future medical applications, subject to clinical validation and regulatory approval.

Clinical studies

Our LumbaCure® equipment is currently being evaluated through clinical investigations involving patients with low back pain in a variety of settings, from chronic conditions to elderly people.  

The performance and therapeutic claims regarding the effects of Lumbacure®  in medical field have yet to be evaluated by a notified body.

Pilot randomized study:

Integration of a Mobilisation Device into a Multidisciplinary Rehabilitation Programme for Chronic Low Back Pain

Study NCT06662032

Manuscrit under peer-review  

Study dates

First patient first visit – June 18, 2024 | Last patient last visit – June 26, 2025

Participants

n = 50 patients with chronic low back pain

Study design

Multi-site, randomized controlled trial embedded within a standard rehabilitation program (2 hours, twice per week for 36 sessions)

Primary objective

To evaluate the impact of integrating LumbaCure® into a conventional rehabilitation protocol for chronic low back pain.

Study design highlights
  • Patients are randomized to either standard rehabilitation or standard rehabilitation with LumbaCure®
  • LumbaCure® is delivered as a structured component within the broader therapeutic framework
Key findings

Preprint available

Exploratory efficacy trial:

Clinical Investigation to Assess the Clinical Performance of the LumbaCure® Intervention on Chronic Low Back Pain Patients.

Study NCT06138002

Non-published data

Study dates

First patient first visit – October 2, 2023 | Last patient last visit – September 12, 2024

Participants

n = 21 patients with chronic low back pain

Study design

Randomized, multi-site study comparing LumbaCure to standard physiotherapist-supervised exercise

Intervention

15-minute sessions, 3 times per week for 1 month

Primary objective

To compare the efficacy of LumbaCure® versus conventional physiotherapy exercises in managing chronic low back pain.

Report available on-demand

Exploratory efficacy trial:

Effect of the LumbaCure® Intervention on Elderly Patients Suffering From cLBP

Study NCT06203886

Non-published data

Study dates

First patient first visit – December 11, 2023 | Last patient last visit – July 18, 2024

Participants

n = 10 elderly patients (>70 years) with chronic low back pain

Study design

Exploratory, non-controlled pilot study conducted in a rest and nursing home setting

Primary objective

To assess the potential impact of LumbaCure® on pain reduction and functional mobility associated with fall risk.

Intervention

LumbaCure® sessions, 15 minutes, 3 times per week over 4 weeks

Report available on-demand

Early Clinical Trial:

Assessing the safety of LumbaCure®

Non-published data

 

Study dates
First patient first visit – August 5, 2022 / Last patient last visit – March 30, 2023
Participants
n = 25 patients with chronic low back pain
Study design

Prospective, single-arm, non-controlled, short-term study (3 sessions over 10 days) conducted across multiple sites in Belgium

Primary objective

To assess the safety profile and patient acceptability of LumbaCure® in individuals with chronic low back pain.

Report on-demand

What participants say about LumbaCure®

Please contact us for detailed results and interest in participating to our clinical development